Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Infinity Pharmaceuticals Company Profile (NASDAQ:INFI)

Consensus Ratings for Infinity Pharmaceuticals (NASDAQ:INFI) (?)
Ratings Breakdown: 2 Hold Rating(s), 7 Buy Rating(s)
Consensus Rating:Buy (Score: 2.78)
Consensus Price Target: $19.13 (39.60% upside)

Analysts' Ratings History for Infinity Pharmaceuticals (NASDAQ:INFI)
Show:
DateFirmActionRatingPrice TargetDetailsShare
9/5/2014NomuraBoost Price Target$12.00 -> $19.00ViewTweet This Rating  Share This Rating on StockTwits
9/4/2014Jefferies GroupBoost Price TargetBuy$13.00 -> $18.00ViewTweet This Rating  Share This Rating on StockTwits
9/4/2014JMP SecuritiesUpgradeMarket Perform -> Outperform$24.00ViewTweet This Rating  Share This Rating on StockTwits
9/3/2014Roth CapitalReiterated RatingPositiveViewTweet This Rating  Share This Rating on StockTwits
9/3/2014WedbushUpgradeUnderperform -> Neutral$9.00 -> $15.00ViewTweet This Rating  Share This Rating on StockTwits
8/6/2014William BlairUpgradeOutperformViewTweet This Rating  Share This Rating on StockTwits
6/25/2014Morgan StanleyInitiated CoverageOverweight$17.00ViewTweet This Rating  Share This Rating on StockTwits
5/9/2014WedbushLower Price Target$10.00 -> $9.00ViewTweet This Rating  Share This Rating on StockTwits
5/7/2014Stifel NicolausReiterated RatingBuy$25.00 -> $20.00ViewTweet This Rating  Share This Rating on StockTwits
5/7/2014JPMorgan Chase & Co.Reiterated RatingOverweight$24.00 -> $20.00ViewTweet This Rating  Share This Rating on StockTwits
5/7/2014Jefferies GroupUpgradeHold -> Buy$15.00 -> $13.00ViewTweet This Rating  Share This Rating on StockTwits
5/7/2014NomuraLower Price Target$17.00 -> $12.00ViewTweet This Rating  Share This Rating on StockTwits
3/3/2014WedbushInitiated CoverageUnderperform$10.00ViewTweet This Rating  Share This Rating on StockTwits
2/26/2014NomuraBoost Price Target$14.00 -> $17.00ViewTweet This Rating  Share This Rating on StockTwits
2/26/2014Jefferies GroupBoost Price Target$13.00 -> $15.00ViewTweet This Rating  Share This Rating on StockTwits
1/8/2014NomuraInitiated CoverageNeutralViewTweet This Rating  Share This Rating on StockTwits
12/12/2013Credit SuisseDowngradeOutperform -> Neutral$20.00ViewTweet This Rating  Share This Rating on StockTwits
9/23/2013William BlairInitiated CoverageMarket Perform$21.00ViewTweet This Rating  Share This Rating on StockTwits
9/18/2013Goldman SachsBoost Price Target$20.00 -> $22.00ViewTweet This Rating  Share This Rating on StockTwits
8/19/2013Morgan StanleyLower Price TargetHold$47.00 -> $25.00ViewTweet This Rating  Share This Rating on StockTwits
7/5/2013Goldman SachsLower Price TargetNeutral$40.00 -> $20.00ViewTweet This Rating  Share This Rating on StockTwits
6/5/2013Jefferies GroupLower Price Target$35.00 -> $20.00ViewTweet This Rating  Share This Rating on StockTwits
6/5/2013Credit SuisseLower Price Target$42.00 -> $32.00ViewTweet This Rating  Share This Rating on StockTwits
6/4/2013RBC CapitalLower Price Target$55.00 -> $35.00ViewTweet This Rating  Share This Rating on StockTwits
5/9/2013Wells Fargo & Co.Initiated CoverageOutperformViewTweet This Rating  Share This Rating on StockTwits
5/8/2013Jefferies GroupLower Price Target$41.00 -> $35.00ViewTweet This Rating  Share This Rating on StockTwits
5/7/2013Goldman SachsInitiated CoverageNeutralViewTweet This Rating  Share This Rating on StockTwits
4/11/2013StephensDowngradeOverweight -> Equal WeightViewTweet This Rating  Share This Rating on StockTwits
4/2/2013JMP SecuritiesInitiated CoverageMarket PerformViewTweet This Rating  Share This Rating on StockTwits
3/11/2013Piper JaffrayInitiated CoverageOverweightViewTweet This Rating  Share This Rating on StockTwits
3/6/2013JPMorgan Chase & Co.Reiterated RatingOverweight$42.00 -> $53.00ViewTweet This Rating  Share This Rating on StockTwits
3/6/2013RBC CapitalBoost Price TargetOutperform$38.00 -> $55.00ViewTweet This Rating  Share This Rating on StockTwits
3/6/2013Stifel NicolausBoost Price TargetBuy$39.00 -> $50.00ViewTweet This Rating  Share This Rating on StockTwits
3/6/2013Jefferies GroupReiterated RatingHold$21.00 -> $41.00ViewTweet This Rating  Share This Rating on StockTwits
3/1/2013Piper JaffrayInitiated CoverageOverweight$53.00ViewTweet This Rating  Share This Rating on StockTwits
2/19/2013Morgan StanleyInitiated CoverageOverweight$47.00ViewTweet This Rating  Share This Rating on StockTwits
2/4/2013MKM PartnersUpgradeBuyViewTweet This Rating  Share This Rating on StockTwits
1/31/2013JPMorgan Chase & Co.Initiated CoverageOverweight$42.00ViewTweet This Rating  Share This Rating on StockTwits
1/15/2013Credit SuisseInitiated CoverageOutperform$42.00ViewTweet This Rating  Share This Rating on StockTwits
12/10/2012Stifel NicolausUpgradeHold -> Buy$30.00ViewTweet This Rating  Share This Rating on StockTwits
11/21/2012RBC CapitalInitiated CoverageOutperform$28.00ViewTweet This Rating  Share This Rating on StockTwits
11/7/2012Jefferies GroupDowngradeBuy -> Hold$18.00 -> $21.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 10/2/2012 forward)
Discuss Infinity Pharmaceuticals